Status:
COMPLETED
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
Lead Sponsor:
Chalmers University of Technology
Collaborating Sponsors:
Memorial Sloan Kettering Cancer Center
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
In this study, the investigators profiled plasma glycosaminoglycans (GAGs) in a retrospective consecutive series of patients with a radiographic finding of renal mass referred to primary surgery for r...
Eligibility Criteria
Inclusion
- Patients with radiographic finding of renal mass referred to primary surgery;
- Healthy volunteers without any history of malignancy.
Exclusion
- No records on date of surgery;
- A pre-operative sample was obtained 50 days or earlier with respect to the date of surgery; - Absence of pre-operative samples following filtering out outliers or laboratory assay failures.
Key Trial Info
Start Date :
April 28 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 18 2018
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT03471897
Start Date
April 28 2016
End Date
January 18 2018
Last Update
April 17 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.